The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.

Over a hot pot dinner in Shanghai in the fall of 2024, former I-Mab Biopharma executives Lei Fang and Jielun Zhu began to plot their

An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.

Biotech’s best-funded AI startup detailed its first AI model on Tuesday, giving a glimpse at what it’s been doing since launching out of stealth nearly

To help with new pilot models aimed at lowering drug costs across Medicaid and Medicare, CMS’ innovation center is ramping up staff. “We are on